Reuters logo
4 months ago
BRIEF-Manitex Capital's affiliate, Valeo Pharma announces partnership for parkinson's disease treatment
April 11, 2017 / 12:22 PM / 4 months ago

BRIEF-Manitex Capital's affiliate, Valeo Pharma announces partnership for parkinson's disease treatment

April 11 (Reuters) - Manitex Capital Inc:

* Manitex Capital Inc's affiliate, Valeo Pharma Inc, announces partnership for a parkinson's disease treatment

* Manitex Capital- entered into partnership with Zambon s.p.a. For exclusive Canadian rights to commercialize new parkinson's disease product Xadago

* Manitex Capital Inc says valeo pharma will pay zambon upfront, regulatory and commercial milestone payments as well as royalties on product sales

* Manitex Capital - under terms of deal, Valeo Pharma to be responsible for all regulatory, sales, marketing, quality, distribution activities in Canada

* Manitex Capital - agreement grants Valeo Pharma exclusive rights to commercialise Zambon's parkinson's disease product, licensed from Newron Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below